A network pharmacology approach for investigating the multi-target mechanisms of Huangqi in the treatment of colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is the third most prevalent cancer globally. In the treatment of CRC, surgical resection is commonly adopted, and neoadjuvant chemotherapy or immunotherapy is mainly administered for patients with advanced disease. However, despite the developments in the field of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Xiao-Dong, Zhang, Yi-Ran, Lin, Zheng-Bin, Zhao, Zhan, Huangfu, Shu-Chen, Qiu, Sheng-Hui, Guo, Yan-Guan, Ding, Hui, Huang, Ting, Chu, Xiao-Li, Pan, Jing-Hua, Pan, Yun-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798599/
https://www.ncbi.nlm.nih.gov/pubmed/35116401
http://dx.doi.org/10.21037/tcr-20-2596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798599/
https://www.ncbi.nlm.nih.gov/pubmed/35116401
http://dx.doi.org/10.21037/tcr-20-2596

Ejemplares similares